SUCCINYLCHOLINE CHLORIDE injection solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

SUCCINYLCHOLINE CHLORIDE (UNII: I9L0DDD30I) (SUCCINYLCHOLINE - UNII:J2R869A8YF)

Available from:

Cantrell Drug Company

INN (International Name):

SUCCINYLCHOLINE CHLORIDE

Composition:

SUCCINYLCHOLINE CHLORIDE 20 mg in 1 mL

Prescription type:

PRESCRIPTION DRUG

Authorization status:

unapproved drug other

Summary of Product characteristics

SUCCINYLCHOLINE CHLORIDE- SUCCINYLCHOLINE CHLORIDE INJECTION, SOLUTION
CANTRELL DRUG COMPANY
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
SUCCINYLCHOLINE CHLORIDE 20 MG/ML INJECTION SOLUTION 10 ML SYRINGE
• WARNINGS AND PRECAUTIONS
Outsourced Compounded Drug. Not for Resale. Hospital/Office Use Only.
WARNING: PARALYZING AGENT. CAUSES RESPIRATORY ARREST.
SUCCINYLCHOLINE SHOULD BE USED ONLY BY THOSE SKILLED IN THE MANAGEMENT
OF ARTIFICIAL RESPIRATION AND ONLY WHEN FACILITIES ARE INSTANTLY
AVAILABLE FOR TRACHEAL INTUBATION AND FOR PROVIDING ADEQUATE
VENTILATION OF THE PATIENT, INCLUDING THE ADMINISTRATION OF OXYGEN
UNDER
POSITIVE PRESSURE AND THE ELIMINATION OF CARBON DIOXIDE. THE CLINICIAN
MUST BE PREPARED TO ASSIST OR CONTROL RESPIRATION.
• ADVERSE EVENTS
To facilitate Adverse Event Reporting: www.fda.gov/medwatch or
1-800-FDA-1088.
• HOW SUPPLIED
Succinylcholine Chloride is supplied as a sterile, isotonic,
nonpyrogenic solution that is clear,
colorless in a 10 mL Single-Dose Syringe.
This product is Preservative-Free and Latex-Free.
• INGREDIENTS
Each 1 mL contains 20 mg Succinylcholine Chloride and made isotonic
with 4.36 mg Sodium Chloride,
USP, in Sterile Water for Injection. The aqueous solution is adjusted
to a pH of 3.5 with hydrochloric
acid and/or sodium hydroxide, if necessary.
• STORAGE AND HANDLING
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room
Temperature].
• DOSAGE AND ADMINISTRATION.
FOR INTRAVENOUS USE. PRESERVATIVE-FREE INJECTION SOLUTION.
The dosage of succinylcholine should be individualized and should
always be determined by the
clinician after careful assessment of the patient.
Parenteral drug products should be inspected visually for particulate
matter and discoloration prior to
administration, whenever solution and container permit. Solutions that
are discolored and/or contain
particulate matter should not be use